Azitra, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AZTR NYSE American 2834 azitrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Azitra, Inc.

/C O R R E C T I O N -- Azitra, Inc./ - Jul 15th, 2026 9:33 am
Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity - Jul 15th, 2026 8:10 am
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond - Jun 17th, 2026 6:00 am
Azitra, Inc. to Present at 2026 BIO International Convention - Jun 16th, 2026 3:28 pm
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting - Jun 4th, 2026 2:05 pm
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting - May 27th, 2026 2:30 pm
AZTR: More Background on Cosmetic Opportunity - May 22nd, 2026 5:15 am
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates - May 13th, 2026 6:30 am
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program - May 6th, 2026 6:00 am
Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris - Apr 28th, 2026 6:02 am
Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million - Mar 19th, 2026 11:13 am
Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement - Mar 13th, 2026 3:15 pm
Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders - Mar 5th, 2026 2:30 pm
AZTR: New Site for ATR-04 Trial - Mar 4th, 2026 1:00 am
Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates - Feb 27th, 2026 3:30 pm
Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash - Feb 24th, 2026 6:00 am
Azitra, Inc. to Present at BIO Investment & Growth Summit - Feb 19th, 2026 6:00 am
Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting - Feb 6th, 2026 2:15 pm
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference - Jan 7th, 2026 6:00 am
Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American - Dec 17th, 2025 2:10 pm